Venture Capital Investors

Genesis Therapeutics

Genesis Therapeutics is a VC investing group that backs technology-based companies.

Venture Investor Overview

Contact Information

Background Information

Overview

Genesis Therapeutics is pioneering generative and predictive AI technologies to develop and commercialize breakthrough treatments for patients suffering from severe and devastating conditions. We are using our proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and/or undruggable targets

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/21/2023

Transaction History

Our records indicate that Genesis Therapeutics invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Evan Feinberg

        

Chief Operating Officer and Chief Financial Officer

Will McCarthy

        

Chief Marketing Officer

Louie Naumovski

        

Chief Technology Officer

Ben Sklaroff

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Genesis Therapeutics has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Genesis Partners | Genesis Trading

Share this article

About Our Venture Capital Investor Database

The venture capital investor data above is provided by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary